英矽智能（03696）今日盘中股价大幅上涨14.95%，市场表现强劲。
消息面上，公司早间宣布与全球制药巨头礼来（Eli Lilly）达成一项全球管线授权与AI药物研发合作。根据协议，礼来将获得一项全球独家授权，用于开发、生产及商业化一款处于临床前阶段、具有“同类最佳”潜力的新型口服疗法。此外，双方将围绕礼来选定的靶点开展多项研发合作，结合英矽智能的Pharma.AI平台与礼来的研发专长。
此次合作对英矽智能意义重大，公司将有资格获得高达1.15亿美元的首付款，并在达成后续开发、监管及商业化里程碑后，获得总额最高可达约27.5亿美元的付款，此外还包括基于未来销售额的分级特许权使用费。这一重磅合作不仅为公司带来了可观的即时现金流，更验证了其AI制药平台的技术实力与商业价值，极大地提振了市场对其未来增长潜力的信心。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments